| Dr Matthew Tyler Crim, MD, MSC, MA | |
|
242 King Avenue, Suite 210, Athens, GA 30606 | |
| (706) 475-1700 | |
| Not Available |
| Full Name | Dr Matthew Tyler Crim |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 13 Years |
| Location | 242 King Avenue, Athens, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588993414 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 077718 (Georgia) | Secondary |
| 207UN0901X | Nuclear Medicine - Nuclear Cardiology | 077718 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Athens Regional Medical Center | Athens, GA | Hospital |
| Piedmont Walton Hospital | Monroe, GA | Hospital |
| Piedmont Newton Hospital | Covington, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Athens Specialty Care Llc | 8820349772 | 99 |
News Archive
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured four late breaking clinical trials at the Hynes Convention Center in Boston.
TELA Bio, Inc., a surgical reconstruction company leading the development and commercialization of Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced the company's OviTex RBSs have been implanted in more than 100 hernia repair procedures since receiving U.S. Food and Drug Administration 510(k) clearance in June 2016.
Johns Hopkins Kimmel Cancer Center scientists have found that interferon, used for 30 years to treat blood cancers, multiple sclerosis and hepatitis, selectively kills colon cancer cells when combined with another standard chemotherapy agent.
The legislation on the table isn't perfect, but it's as good as anyone could reasonably have expected. History is about to be made — and everyone has to decide which side they're on (Paul Krugman, 10/29).
› Verified 5 days ago
| Entity Name | Piedmont Cardiology Of Atlanta, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275729691 PECOS PAC ID: 0345321691 Enrollment ID: O20080114000153 |
News Archive
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured four late breaking clinical trials at the Hynes Convention Center in Boston.
TELA Bio, Inc., a surgical reconstruction company leading the development and commercialization of Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced the company's OviTex RBSs have been implanted in more than 100 hernia repair procedures since receiving U.S. Food and Drug Administration 510(k) clearance in June 2016.
Johns Hopkins Kimmel Cancer Center scientists have found that interferon, used for 30 years to treat blood cancers, multiple sclerosis and hepatitis, selectively kills colon cancer cells when combined with another standard chemotherapy agent.
The legislation on the table isn't perfect, but it's as good as anyone could reasonably have expected. History is about to be made — and everyone has to decide which side they're on (Paul Krugman, 10/29).
› Verified 5 days ago
| Entity Name | Athens Regional Specialty Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083939136 PECOS PAC ID: 8325162340 Enrollment ID: O20100827000645 |
News Archive
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured four late breaking clinical trials at the Hynes Convention Center in Boston.
TELA Bio, Inc., a surgical reconstruction company leading the development and commercialization of Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced the company's OviTex RBSs have been implanted in more than 100 hernia repair procedures since receiving U.S. Food and Drug Administration 510(k) clearance in June 2016.
Johns Hopkins Kimmel Cancer Center scientists have found that interferon, used for 30 years to treat blood cancers, multiple sclerosis and hepatitis, selectively kills colon cancer cells when combined with another standard chemotherapy agent.
The legislation on the table isn't perfect, but it's as good as anyone could reasonably have expected. History is about to be made — and everyone has to decide which side they're on (Paul Krugman, 10/29).
› Verified 5 days ago
| Entity Name | Piedmont Athens Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184130627 PECOS PAC ID: 8820349772 Enrollment ID: O20180917001273 |
News Archive
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured four late breaking clinical trials at the Hynes Convention Center in Boston.
TELA Bio, Inc., a surgical reconstruction company leading the development and commercialization of Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced the company's OviTex RBSs have been implanted in more than 100 hernia repair procedures since receiving U.S. Food and Drug Administration 510(k) clearance in June 2016.
Johns Hopkins Kimmel Cancer Center scientists have found that interferon, used for 30 years to treat blood cancers, multiple sclerosis and hepatitis, selectively kills colon cancer cells when combined with another standard chemotherapy agent.
The legislation on the table isn't perfect, but it's as good as anyone could reasonably have expected. History is about to be made — and everyone has to decide which side they're on (Paul Krugman, 10/29).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Tyler Crim, MD, MSC, MA 2727 Paces Ferry Road, Suite 1-1100, Atlanta, GA 30339-6150 Ph: (470) 271-3421 | Dr Matthew Tyler Crim, MD, MSC, MA 242 King Avenue, Suite 210, Athens, GA 30606 Ph: (706) 475-1700 |
News Archive
Some new health insurance plans sold through the health law's online insurance exchanges - in an effort to keep premiums down - severely limit where new enrollees can get care.
The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured four late breaking clinical trials at the Hynes Convention Center in Boston.
TELA Bio, Inc., a surgical reconstruction company leading the development and commercialization of Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced the company's OviTex RBSs have been implanted in more than 100 hernia repair procedures since receiving U.S. Food and Drug Administration 510(k) clearance in June 2016.
Johns Hopkins Kimmel Cancer Center scientists have found that interferon, used for 30 years to treat blood cancers, multiple sclerosis and hepatitis, selectively kills colon cancer cells when combined with another standard chemotherapy agent.
The legislation on the table isn't perfect, but it's as good as anyone could reasonably have expected. History is about to be made — and everyone has to decide which side they're on (Paul Krugman, 10/29).
› Verified 5 days ago